Rwanda

Rwanda

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
3.8 (3.07 - 4.54) 2019 Modelled IHME
3.85 (3.10 - 4.57) 2018 Modelled IHME
3.95 (3.17 - 4.72) 2017 Modelled IHME
4.18 (3.38 - 5.02) 2016 Modelled IHME
4.44 (3.62 - 5.43) 2015 Modelled IHME
4.59 (3.73 - 5.60) 2014 Modelled IHME
4.71 (3.82 - 5.73) 2013 Modelled IHME
4.82 (3.88 - 5.86) 2012 Modelled IHME
4.93 (3.93 - 6.01) 2011 Modelled IHME
5.08 (4.02 - 6.18) 2010 Modelled IHME
5.27 (4.19 - 6.42) 2009 Modelled IHME
5.52 (4.45 - 6.73) 2008 Modelled IHME
5.78 (4.74 - 7.04) 2007 Modelled IHME
6.03 (4.93 - 7.40) 2006 Modelled IHME
6.23 (5.05 - 7.71) 2005 Modelled IHME
6.41 (5.17 - 7.94) 2004 Modelled IHME
6.59 (5.29 - 8.14) 2003 Modelled IHME
6.75 (5.37 - 8.35) 2002 Modelled IHME
6.87 (5.40 - 8.51) 2001 Modelled IHME
6.91 (5.41 - 8.65) 2000 Modelled IHME
6.91 (5.44 - 8.48) 1999 Modelled IHME
6.89 (5.45 - 8.36) 1998 Modelled IHME
6.86 (5.48 - 8.20) 1997 Modelled IHME
6.83 (5.48 - 8.12) 1996 Modelled IHME
6.82 (5.48 - 8.13) 1995 Modelled IHME
6.82 (5.49 - 8.07) 1994 Modelled IHME
6.81 (5.46 - 8.07) 1993 Modelled IHME
6.8 (5.41 - 8.12) 1992 Modelled IHME
6.8 (5.41 - 8.21) 1991 Modelled IHME
6.8 (5.37 - 8.37) 1990 Modelled IHME
4.52 (2.50 - 7.74) 2015 Modelled WHO
3.9 (3.83 - 3.97) 2018 Survey/reported Makuza et al, 2019
6.67 (3.82 - 11.37) 2013 Modelled Schweitzer et al, 2015
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.35 (0.26 - 0.47) 2019 Modelled IHME
0.38 (0.28 - 0.51) 2018 Modelled IHME
0.4 (0.30 - 0.53) 2017 Modelled IHME
0.41 (0.30 - 0.53) 2016 Modelled IHME
0.42 (0.30 - 0.54) 2015 Modelled IHME
0.43 (0.32 - 0.56) 2014 Modelled IHME
0.47 (0.34 - 0.60) 2013 Modelled IHME
0.51 (0.38 - 0.66) 2012 Modelled IHME
0.57 (0.42 - 0.73) 2011 Modelled IHME
0.63 (0.46 - 0.82) 2010 Modelled IHME
0.72 (0.54 - 0.94) 2009 Modelled IHME
0.87 (0.64 - 1.13) 2008 Modelled IHME
1.06 (0.77 - 1.38) 2007 Modelled IHME
1.29 (0.93 - 1.69) 2006 Modelled IHME
1.57 (1.12 - 2.08) 2005 Modelled IHME
2.13 (1.53 - 2.81) 2004 Modelled IHME
3.04 (2.21 - 4) 2003 Modelled IHME
4.03 (2.94 - 5.30) 2002 Modelled IHME
4.82 (3.50 - 6.37) 2001 Modelled IHME
5.15 (3.72 - 6.88) 2000 Modelled IHME
5.15 (3.77 - 6.83) 1999 Modelled IHME
5.13 (3.75 - 6.83) 1998 Modelled IHME
5.12 (3.74 - 6.86) 1997 Modelled IHME
5.11 (3.73 - 6.85) 1996 Modelled IHME
5.1 (3.73 - 6.98) 1995 Modelled IHME
5.09 (3.76 - 6.84) 1994 Modelled IHME
5.09 (3.77 - 6.84) 1993 Modelled IHME
5.09 (3.78 - 6.79) 1992 Modelled IHME
5.08 (3.79 - 6.69) 1991 Modelled IHME
5.08 (3.77 - 6.66) 1990 Modelled IHME
1.74 (0.86 - 3.30) 2015 Modelled WHO
Showing out of
Show more
People living with HIV (PLHIV)
Download
Value (%) Year Type Source
4.3 (4.20 - 4.40) 2016 Survey/reported Umutesi J et al, 2017

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.71 (1.85 - 3.78) 2019 Modelled IHME
2.79 (1.92 - 3.95) 2018 Modelled IHME
2.8 (1.95 - 3.91) 2017 Modelled IHME
2.76 (1.90 - 3.84) 2016 Modelled IHME
2.73 (1.88 - 3.80) 2015 Modelled IHME
2.8 (1.95 - 3.91) 2014 Modelled IHME
2.99 (2.08 - 4.21) 2013 Modelled IHME
3.25 (2.26 - 4.51) 2012 Modelled IHME
3.45 (2.41 - 4.78) 2011 Modelled IHME
3.56 (2.50 - 4.98) 2010 Modelled IHME
3.61 (2.55 - 4.96) 2009 Modelled IHME
3.73 (2.66 - 5.06) 2008 Modelled IHME
3.84 (2.76 - 5.23) 2007 Modelled IHME
3.99 (2.87 - 5.41) 2006 Modelled IHME
4.19 (3 - 5.73) 2005 Modelled IHME
4.39 (3.12 - 6.09) 2004 Modelled IHME
4.57 (3.21 - 6.33) 2003 Modelled IHME
4.8 (3.38 - 6.71) 2002 Modelled IHME
5.07 (3.56 - 7.18) 2001 Modelled IHME
5.42 (3.73 - 7.82) 2000 Modelled IHME
5.74 (3.86 - 8.28) 1999 Modelled IHME
5.97 (3.93 - 8.62) 1998 Modelled IHME
6.03 (3.86 - 8.64) 1997 Modelled IHME
6.11 (3.89 - 8.80) 1996 Modelled IHME
6.2 (3.95 - 8.92) 1995 Modelled IHME
6.37 (4.16 - 9.03) 1994 Modelled IHME
6.32 (4.09 - 8.93) 1993 Modelled IHME
6.14 (3.98 - 8.59) 1992 Modelled IHME
6.03 (3.99 - 8.41) 1991 Modelled IHME
5.96 (4 - 8.30) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
343 (235 - 480) 2019 Modelled IHME
346 (238 - 490) 2018 Modelled IHME
340 (236 - 475) 2017 Modelled IHME
328 (226 - 456) 2016 Modelled IHME
317 (218 - 440) 2015 Modelled IHME
317 (221 - 443) 2014 Modelled IHME
333 (232 - 468) 2013 Modelled IHME
354 (246 - 491) 2012 Modelled IHME
366 (256 - 507) 2011 Modelled IHME
367 (258 - 514) 2010 Modelled IHME
363 (257 - 498) 2009 Modelled IHME
365 (261 - 496) 2008 Modelled IHME
368 (264 - 501) 2007 Modelled IHME
373 (268 - 505) 2006 Modelled IHME
381 (273 - 522) 2005 Modelled IHME
390 (277 - 541) 2004 Modelled IHME
397 (279 - 550) 2003 Modelled IHME
407 (286 - 568) 2002 Modelled IHME
419 (294 - 594) 2001 Modelled IHME
438 (301 - 632) 2000 Modelled IHME
454 (305 - 655) 1999 Modelled IHME
464 (306 - 670) 1998 Modelled IHME
459 (294 - 658) 1997 Modelled IHME
426 (272 - 614) 1996 Modelled IHME
372 (237 - 534) 1995 Modelled IHME
339 (222 - 481) 1994 Modelled IHME
349 (226 - 493) 1993 Modelled IHME
415 (269 - 581) 1992 Modelled IHME
446 (295 - 622) 1991 Modelled IHME
427 (287 - 596) 1990 Modelled IHME
696 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
28 (21 - 36) 2019 Modelled IHME
28 (21 - 36) 2018 Modelled IHME
28 (21 - 36) 2017 Modelled IHME
28 (21 - 36) 2016 Modelled IHME
28 (21 - 36) 2015 Modelled IHME
28 (21 - 36) 2014 Modelled IHME
28 (22 - 36) 2013 Modelled IHME
29 (22 - 37) 2012 Modelled IHME
29 (22 - 37) 2011 Modelled IHME
29 (22 - 37) 2010 Modelled IHME
29 (22 - 37) 2009 Modelled IHME
29 (22 - 37) 2008 Modelled IHME
29 (23 - 37) 2007 Modelled IHME
29 (23 - 37) 2006 Modelled IHME
29 (23 - 37) 2005 Modelled IHME
29 (23 - 37) 2004 Modelled IHME
30 (23 - 38) 2003 Modelled IHME
30 (23 - 38) 2002 Modelled IHME
30 (23 - 39) 2001 Modelled IHME
30 (23 - 39) 2000 Modelled IHME
30 (23 - 39) 1999 Modelled IHME
30 (23 - 39) 1998 Modelled IHME
29 (22 - 39) 1997 Modelled IHME
29 (22 - 38) 1996 Modelled IHME
29 (22 - 38) 1995 Modelled IHME
28 (21 - 37) 1994 Modelled IHME
28 (21 - 37) 1993 Modelled IHME
28 (21 - 37) 1992 Modelled IHME
28 (21 - 37) 1991 Modelled IHME
28 (21 - 37) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
97 2018 Survey/reported WHO/UNICEF
98 2017 Survey/reported WHO/UNICEF
98 2016 Survey/reported WHO/UNICEF
98 2015 Survey/reported WHO/UNICEF
98 2014 Survey/reported WHO/UNICEF
98 2013 Survey/reported WHO/UNICEF
98 2012 Survey/reported WHO/UNICEF
97 2011 Survey/reported WHO/UNICEF
97 2010 Survey/reported WHO/UNICEF
97 2009 Survey/reported WHO/UNICEF
97 2008 Survey/reported WHO/UNICEF
97 2007 Survey/reported WHO/UNICEF
99 2006 Survey/reported WHO/UNICEF
95 2005 Survey/reported WHO/UNICEF
89 2004 Survey/reported WHO/UNICEF
96 2003 Survey/reported WHO/UNICEF
88 2002 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HBV testing policy
No
HepB birth dose policy
Yes
Year of birth dose introduction
2016
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2024
HCV testing policy
Universal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.72 (1.39 - 2.13) 2019 Modelled IHME
1.71 (1.39 - 2.11) 2018 Modelled IHME
1.71 (1.38 - 2.11) 2017 Modelled IHME
1.7 (1.38 - 2.11) 2016 Modelled IHME
1.7 (1.37 - 2.12) 2015 Modelled IHME
1.7 (1.38 - 2.13) 2014 Modelled IHME
1.71 (1.38 - 2.13) 2013 Modelled IHME
1.72 (1.38 - 2.15) 2012 Modelled IHME
1.74 (1.39 - 2.16) 2011 Modelled IHME
1.75 (1.40 - 2.18) 2010 Modelled IHME
1.77 (1.41 - 2.20) 2009 Modelled IHME
1.79 (1.42 - 2.22) 2008 Modelled IHME
1.81 (1.45 - 2.26) 2007 Modelled IHME
1.83 (1.47 - 2.28) 2006 Modelled IHME
1.86 (1.50 - 2.31) 2005 Modelled IHME
1.89 (1.52 - 2.34) 2004 Modelled IHME
1.92 (1.55 - 2.39) 2003 Modelled IHME
1.96 (1.58 - 2.42) 2002 Modelled IHME
1.99 (1.60 - 2.47) 2001 Modelled IHME
2.02 (1.62 - 2.51) 2000 Modelled IHME
2.04 (1.65 - 2.53) 1999 Modelled IHME
2.06 (1.67 - 2.56) 1998 Modelled IHME
2.09 (1.69 - 2.60) 1997 Modelled IHME
2.1 (1.70 - 2.62) 1996 Modelled IHME
2.12 (1.71 - 2.63) 1995 Modelled IHME
2.13 (1.72 - 2.65) 1994 Modelled IHME
2.13 (1.73 - 2.66) 1993 Modelled IHME
2.14 (1.73 - 2.66) 1992 Modelled IHME
2.15 (1.73 - 2.66) 1991 Modelled IHME
2.15 (1.72 - 2.68) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
8.86 (8.70 - 9.02) 2017 Survey/reported Umutesi J et al, 2019
3.1 (0.30 - 9) 2014 Modelled Riou et al, 2015
3.1 (0.30 - 12) 2017 Modelled Sonderup et al, 2017
Showing out of
Show more
People living with HIV (PLHIV)
Download
Value (%) Year Type Source
4.6 (4.50 - 4.70) 2016 Survey/reported Umutesi J et al, 2017

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
9.7 (6.91 - 13.50) 2019 Modelled IHME
9.57 (6.83 - 13.30) 2018 Modelled IHME
9.39 (6.68 - 12.90) 2017 Modelled IHME
9.22 (6.61 - 12.60) 2016 Modelled IHME
9.12 (6.52 - 12.40) 2015 Modelled IHME
8.95 (6.53 - 12.20) 2014 Modelled IHME
8.72 (6.47 - 11.70) 2013 Modelled IHME
8.57 (6.47 - 11.40) 2012 Modelled IHME
8.41 (6.37 - 11.10) 2011 Modelled IHME
8.37 (6.42 - 11) 2010 Modelled IHME
8.46 (6.51 - 11.10) 2009 Modelled IHME
8.68 (6.68 - 11.10) 2008 Modelled IHME
8.91 (6.94 - 11.40) 2007 Modelled IHME
9.21 (7.20 - 11.60) 2006 Modelled IHME
9.64 (7.59 - 12) 2005 Modelled IHME
10 (7.81 - 12.40) 2004 Modelled IHME
10.3 (7.89 - 12.70) 2003 Modelled IHME
10.6 (8.05 - 13.30) 2002 Modelled IHME
11 (8.22 - 13.90) 2001 Modelled IHME
11.7 (8.65 - 15.20) 2000 Modelled IHME
12.5 (9.07 - 16.30) 1999 Modelled IHME
13.3 (9.64 - 17.30) 1998 Modelled IHME
13.7 (9.70 - 17.70) 1997 Modelled IHME
14.2 (9.96 - 18.30) 1996 Modelled IHME
14.7 (10.50 - 18.90) 1995 Modelled IHME
15.5 (11.20 - 19.80) 1994 Modelled IHME
15.4 (11.10 - 19.90) 1993 Modelled IHME
14.7 (10.50 - 19) 1992 Modelled IHME
14.3 (10.20 - 18.50) 1991 Modelled IHME
14.2 (10.20 - 18.30) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
1,231 (877 - 1,714) 2019 Modelled IHME
1,187 (848 - 1,647) 2018 Modelled IHME
1,141 (811 - 1,566) 2017 Modelled IHME
1,095 (785 - 1,495) 2016 Modelled IHME
1,057 (756 - 1,441) 2015 Modelled IHME
1,014 (740 - 1,381) 2014 Modelled IHME
971 (720 - 1,305) 2013 Modelled IHME
933 (704 - 1,245) 2012 Modelled IHME
891 (675 - 1,181) 2011 Modelled IHME
864 (662 - 1,135) 2010 Modelled IHME
849 (654 - 1,117) 2009 Modelled IHME
850 (654 - 1,092) 2008 Modelled IHME
853 (664 - 1,090) 2007 Modelled IHME
860 (673 - 1,084) 2006 Modelled IHME
877 (690 - 1,095) 2005 Modelled IHME
888 (694 - 1,105) 2004 Modelled IHME
892 (685 - 1,106) 2003 Modelled IHME
898 (682 - 1,126) 2002 Modelled IHME
909 (680 - 1,146) 2001 Modelled IHME
948 (699 - 1,225) 2000 Modelled IHME
992 (717 - 1,291) 1999 Modelled IHME
1,033 (750 - 1,344) 1998 Modelled IHME
1,040 (738 - 1,350) 1997 Modelled IHME
988 (695 - 1,277) 1996 Modelled IHME
884 (630 - 1,135) 1995 Modelled IHME
825 (594 - 1,053) 1994 Modelled IHME
853 (612 - 1,099) 1993 Modelled IHME
995 (710 - 1,283) 1992 Modelled IHME
1,061 (758 - 1,368) 1991 Modelled IHME
1,018 (729 - 1,313) 1990 Modelled IHME
900 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
21 (14 - 28) 2019 Modelled IHME
21 (14 - 28) 2018 Modelled IHME
21 (14 - 28) 2017 Modelled IHME
21 (14 - 27) 2016 Modelled IHME
20 (14 - 27) 2015 Modelled IHME
20 (14 - 27) 2014 Modelled IHME
20 (14 - 27) 2013 Modelled IHME
20 (14 - 27) 2012 Modelled IHME
20 (14 - 27) 2011 Modelled IHME
20 (14 - 27) 2010 Modelled IHME
20 (14 - 26) 2009 Modelled IHME
19 (14 - 26) 2008 Modelled IHME
19 (13 - 26) 2007 Modelled IHME
19 (13 - 26) 2006 Modelled IHME
19 (13 - 25) 2005 Modelled IHME
19 (13 - 25) 2004 Modelled IHME
19 (13 - 25) 2003 Modelled IHME
19 (13 - 25) 2002 Modelled IHME
19 (13 - 25) 2001 Modelled IHME
18 (13 - 25) 2000 Modelled IHME
19 (13 - 25) 1999 Modelled IHME
19 (13 - 25) 1998 Modelled IHME
19 (13 - 26) 1997 Modelled IHME
19 (13 - 26) 1996 Modelled IHME
20 (13 - 27) 1995 Modelled IHME
20 (14 - 27) 1994 Modelled IHME
20 (14 - 27) 1993 Modelled IHME
20 (13 - 27) 1992 Modelled IHME
19 (13 - 27) 1991 Modelled IHME
19 (13 - 26) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HBV testing policy
No
HepB birth dose policy
Yes
Year of birth dose introduction
2016
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2024
HCV testing policy
Universal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)

Overview

HBV elimination goal
HCV elimination goal
Year of goal
2024

Hepatitis related deaths (national)

Modelled

HBV
343
2019
(235 - 480)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
1,231
2019
(877 - 1,714)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources